Augmedit B.V.

Naarden, Netherlands All Netherlands companies → — Founded 2018

Imaging AI Specialist Specialty-Focused AI

Neurosurgery Radiology

Neurology AI Radiology & Imaging AI Surgical AI

Series A

Claim this company

About Augmedit B.V.

Augmedit B.V. is a healthcare AI company specializing in augmented reality (AR) software for surgical applications. Their mission is to transform 2D medical imaging into interactive 3D holograms, aiming to enhance surgical planning, intra-operative guidance, and patient education. The company’s core products, Lumi™ and LumiNE, enable surgeons and their teams to convert DICOM images into detailed 3D segmented models. LumiNE Lite focuses on neurosurgical planning, automatically segmenting relevant anatomical structures from head scans, while LumiNE Elite projects these holograms onto the patient during surgery for real-time visualization and guidance, particularly for procedures like External Ventricular Drain (EVD) placement.

This AR-based system is designed to improve surgeons’ insights, potentially leading to safer procedures and reduced costs for medical institutions. Augmedit emphasizes a complete and intuitive AR workflow, offering a low-priced subscription model and hardware-agnostic compatibility with devices like HoloLens 2. The technology is also utilized for shared decision-making, as patient-specific 3D holograms can enhance patient understanding and engagement, fostering improved communication between clinicians and patients.

Focus Areas

augmented reality mixed reality neurosurgery medical education holographic visualization neuronavigation surgical planning intraoperative guidance medical imaging AI-driven segmentation

Business Intelligence

Technology

Cloud-native, AI-based algorithms for semi-automatic segmentation, compatible with wireless Head-Mounted Displays (HMDs) like HoloLens 2, web, and mobile (coming soon).

What Physicians Need to Know

Augmented Reality & 3D Visualization

Augmedit specializes in converting 2D medical images (MRI, CT scans) into interactive 3D holograms for enhanced visualization in surgical planning and intraoperative guidance. Their technology allows surgeons to view patient-specific anatomy and pathology in 3D using AR headsets like Microsoft HoloLens 2.

Artificial Intelligence

The company leverages AI algorithms for automatic segmentation of relevant anatomical structures (e.g., brain, ventricles, tumors, skin) from medical scans, streamlining the creation of 3D models.

Surgical Planning & Intraoperative Use

Augmedit's software, including Lumi and LumiNE Elite, is designed to improve surgical preparation and provide real-time AR guidance during procedures. This includes applications in neurosurgery for tasks like External Ventricular Drain (EVD) placement.

Neurosurgery Focus

A significant area of specialization is neurosurgery, where their AR tools assist in understanding brain tumors and anatomy, surgical planning, and intraoperative visualization.

Patient Education & Medical Training

Augmedit's 3D holograms enhance patient understanding and engagement, improving patient-clinician communication. The technology also offers immersive medical training for staff.

Oral and Maxillofacial Surgery

While a strong focus is on neurosurgery, Augmedit is also expanding its technology to high-volume, high-impact indications beyond neurosurgery, including oral and maxillofacial surgery.

Physician Tip

Augmedit's solutions offer physicians enhanced spatial understanding of complex anatomy and pathology through interactive 3D holograms, directly from 2D scans. This can lead to improved surgical planning, increased precision during procedures, and better patient communication and education. The hardware-agnostic approach and subscription model make it a flexible and accessible tool. For neurosurgeons, specifically, the LumiNE Elite module provides intra-operative visualization for procedures like EVD placement.

Augmedit's system connects DICOM images with their secure Lumi cloud, converting them into 3D segmented models. The platform is hardware agnostic and compatible with Microsoft HoloLens 2, web, and upcoming mobile applications. They utilize AI-based algorithms for segmentation and are actively involved in research and development with academic partners like UMC Utrecht and University Hospital Zurich.

Products by Augmedit B.V.

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

Augmedit B.V. is a Dutch company specializing in augmented reality (AR) and mixed reality (MR) for neurosurgery and medical education. They focus on converting 2D patient imaging into 3D models and visualizing them using AR, particularly with Microsoft HoloLens 2. Their product, LumiNE US, utilizes AI algorithms for semi-automatic image segmentation to enhance surgical planning. While direct reviews for Augmedit B.V. are limited on major platforms, the company has received a Eurostars Grant for their AR tools and has published research on augmented reality neuronavigation systems. It's important to distinguish Augmedit B.V. from "Augmedix," a different company providing AI-powered medical documentation, which has more extensive reviews available.

Overall: Mixed

Strengths

Specializes in augmented reality and mixed reality for neurosurgery and medical education.
Converts 2D patient imaging into 3D models for visualization.
Utilizes AI algorithms for semi-automatic image segmentation in surgical planning.
Product LumiNE US works with Microsoft HoloLens 2 for interactive 3D model manipulation.
Received a Eurostars Grant for further development of AR tools for surgeons.
Published research on the accuracy of augmented reality neuronavigation systems.

Limitations

Limited publicly available product or employer reviews on major platforms like G2, Glassdoor, Capterra, or Reddit for Augmedit B.V. (as opposed to Augmedix).
Specific details on user experience and satisfaction with LumiNE US are not readily available in the search results.
No information found regarding company culture, salaries, or work-life balance for Augmedit B.V. employees.
The distinction between Augmedit B.V. and Augmedix can lead to confusion when searching for reviews.

Based on reviews from: Legalcomplex Dashboard, accessdata.fda.gov, G2, Augmedit News and Publications, Indeed.com, Reddit

Last updated: 2026-10-18

Videos

News, demos, and interviews about Augmedit B.V..

Loading videos...

Videos load interactively. If none appear, search YouTube for Augmedit B.V. →

View all on YouTube

Press & Coverage

Augmedit

Launch Announcement: LumiNE Elite Achieves CE Approval

Augmedit's LumiNE Elite, an intraoperative software for neurosurgical visualization, received CE approval in January 2026. This allows the product to be marketed and used in Europe.

2026-01

J Neurol Surg Rep

Intraoperative Evaluation of Semiautomatic Localization of the Facial Nerve Using Diffusion Tensor Imaging in Patients with Large Vestibular Schwannomas: A Pilot Study

This peer-reviewed article, published in May 2026, details a pilot study on the intraoperative evaluation of semiautomatic facial nerve localization using DTI in patients with large vestibular schwannomas.

2026-05

UMC Utrecht's research

First brain surgeries performed using holograms

UMC Utrecht, in collaboration with Augmedit, developed a method using AI to convert 2D MRI/CT images into interactive brain holograms for real-time surgical guidance.

2026-01

Augmedit

Augmedit Announces First Closing of Series A Round Led by Egeria Impact Investments, Joined by EIC Fund

Augmedit announced the first closing of its Series A funding round in June 2025, with Egeria Impact Investments leading and the EIC Fund participating.

2025-06

Acta Neurochir (Wien)

Comparing augmented reality-assisted and freehand external ventricular drain placement: a multicenter randomized controlled crossover phantom study

This multicenter randomized controlled crossover phantom study, published in December 2025, compared augmented reality-assisted and freehand external ventricular drain placement.

2025-12

Oper Neurosurg

Artificial Intelligence-Driven 3-Dimensional Segmentation of Pediatric Brain Tumors Based on Navigated Intraoperative Ultrasound

This peer-reviewed article, published in November 2025, discusses AI-driven 3D segmentation of pediatric brain tumors using navigated intraoperative ultrasound.

2025-11

Augmedit

LumiNE US Software Receives FDA Clearance for Surgical Planning

Augmedit's LumiNE US software received FDA 510(k) clearance in September 2024 for use in surgical planning, converting 2D patient imaging into 3D models.

2024-09

Augmedit

Augmedit Closes Seed Investment Round

In November 2022, Augmedit closed a seed investment round of over €1M with Dutch and Swiss investors and US-based Revere Partners, along with a €1.7M non-dilutive grant from the EIC Accelerator program.

2022-11

Frequently Asked Questions

What specific Augmented Reality and Artificial Intelligence products does Augmedit B.V. offer for surgical planning and intraoperative guidance?

Augmedit B.V. offers the Lumi™ software, which converts 2D medical images (MRI, CT scans) into 3D segmented models and holograms for surgical preparation and patient education. Their LumiNE Lite module is specifically designed for neurosurgical planning, converting head scans into 3D models with automatically segmented anatomical structures. The LumiNE Elite module provides intraoperative neurosurgical visualization by registering these holograms onto the patient's head, particularly for procedures like External Ventricular Drain (EVD) placement.

How does Augmedit B.V. ensure compliance and regulatory approval for its medical devices, especially concerning AI and AR technologies?

Augmedit B.V. prioritizes compliance, having achieved CE mark certification for its LumiNE Lite software in Europe and FDA clearance for LumiNE US software in September 2024. They work with notified bodies specializing in AI medical devices to ensure adherence to regulations like EU MDR and ISO 13485. Their devices are intended for visualization and surgical preparation, not diagnostic use, and comply with requirements such as the Unique Device Identification System (UDI) Rule.

What is the pricing model for Augmedit B.V.'s solutions, and what kind of support can physicians and healthcare administrators expect?

Augmedit B.V. utilizes a low-priced subscription model for its software. While specific details on support were not extensively detailed, their instructions for use indicate that users should contact Augmedit B.V. immediately in case of device failure. The company's mission emphasizes providing safe, reliable, affordable, and easy-to-use holograms.

What partnerships does Augmedit B.V. have, particularly in neurosurgery and oral and maxillofacial surgery, and how do these enhance their offerings?

Augmedit B.V. has partnered with UMC Utrecht, where their technology originated, and has sold subscriptions to institutions like UMC Utrecht and USZ Zurich. They also collaborate with Microsoft, utilizing the HoloLens 2 for their AR applications. In oral and maxillofacial surgery, Augmedit has a partnership with US-based Venture Capital Fund Revere Partners, which is focused on oral health innovations, aiming to accelerate market access in the US and develop future products in this field.

What is the current company stability and growth trajectory of Augmedit B.V.?

Augmedit B.V. was founded in 2018 and has demonstrated a strong growth trajectory, securing seed investment rounds and a €1.7 million non-dilutive grant from the EIC Accelerator program. They have achieved CE certification and FDA clearance for their products and are actively expanding their team and market reach in both Europe and the USA. The company aims to become a leader in medical augmented reality applications.

How do Augmedit B.V.'s solutions contribute to patient education and medical training, beyond direct surgical applications?

Augmedit B.V.'s patient-specific 3D holograms enhance patient understanding and engagement, leading to improved patient-clinician communication and shared decision-making. The technology is also valuable for training medical staff and residents, offering immersive medical training experiences. By converting 2D scans into interactive 3D models, Augmedit provides a powerful visual aid for explaining complex procedures.

Can Augmedit B.V.'s 3D visualization and AR technology be integrated with existing hospital systems and hardware?

Augmedit B.V.'s solutions are designed to be hardware agnostic, compatible with devices like the Microsoft HoloLens 2, as well as web and upcoming mobile platforms. Their system connects DICOM images with a secure cloud for 3D model conversion, suggesting an integration capability with standard medical imaging systems. The company aims to enrich existing surgical workflows with intuitive Augmented Reality.

Related Companies

Suggest an Edit → | Report an issue